Sai Life Sciences Limited IPO

Mainboard

Pharmaceuticals

Listed On: Dec 18, 2024 at ₹ 650.0(NSE)

₹ 14823 /27 Shares

Check Allotment

11 Dec, 2024

Open Date

13 Dec, 2024

Close Date

16 Dec, 2024

Allotment Date

18 Dec, 2024

Listing Date

Price Summary

Last Closing

925.00 (68.49%)

52 Week High

943.00

52 Week Low

636.10

Last Update

3-Nov-2025 3:30 PM

Sai Life Sciences IPO Issue Details

Issue Price ₹522-549 per equity share
Face Value ₹1 Per Equity Share
Total Issue Size 5,54,21,123 shares(aggregating up to ₹3042.62 crore)
Fresh Share 1,73,04,189 shares(aggregating up to ₹950 crore)
Offer For Sale 3,81,16,934 shares(aggregating up to ₹2092.62 crore)
Listing at BSE, NSE
List Price 650.0(NSE)
Listing Date 2024-12-18
Lead Manager Kotak Mahindra Capital Company Limited
Jefferies India Private Limited
Morgan Stanley India Company Pvt Ltd
Iifl Securities Ltd
Registrar Kfin Technologies Limited

Market Lot Size

Investors can bid for a minimum of 27 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Retail Investors and HNI in terms of shares and amount.

Application	Lots	Shares	Amount
Retail (min)	1	27	₹14,823
Retail(max)	13	351	₹1,92,699

Sai Life Sciences IPO Reservation

Sai Life Sciences IPO offers total 5,54,21,121 shares. Out of which 1,10,84,225 (20%) allocated to QIB, 83,13,168 (15%) allocated to NII,1,93,97,392 (35%) allocated to RII, NA (NA%) allocated to employees and 1,66,26,336 (30%) allocated to Anchor investors.

Investor Category	Shares Offered	Maximum Allottees
Anchor Investor Shares Offered	1,66,26,336 (30%)
QIB Shares Offered	1,10,84,225 (20%)
NII (HNI) Shares Offered	83,13,168 (15%)
bNII < ₹10L	55,42,113 (10%)
sNII < ₹10L	27,71,056 (5%)
Retail Shares Offered	1,93,97,392 (35%)
Total Shares Offered	5,54,21,121 (100%)

Sai Life Sciences IPO Documents

DRHP

RHP

ANCHOR

Sai Life Sciences IPO Details

Sai Life Sciences IPO is a book-built issue of ₹3042.62 crores, The total issue size is ₹3042.62 crores. The IPO of Sai Life Sciences is priced at ₹522-549 per equity share, which has a face value of ₹1 Per Equity Share each, IPO bidding starts from Dec 11, 2024 and ends on Dec 13, 2024. The allotment for Sai Life Sciences IPO will be finalized on Dec 16, 2024. Sai Life Sciences IPO will be listed on BSE, NSE, with a tentative listing date fixed as Dec 18, 2024. The company shall list its equity shares on the BSE, NSE. Kfin Technologies Limited is the registrar of the issue.

Retail investors can bid for a minimum of 27 shares, extendable to 14,823. The book-running lead manager for the IPO is/are Kotak Mahindra Capital Company Limited, Jefferies India Private Limited, Morgan Stanley India Company Pvt Ltd, Iifl Securities Ltd.

The total issue ₹3042.62 crore, comprising a fresh issue of 1,73,04,189 shares ₹950 crore and having Offer for Sale (OFS) of 3,81,16,934 shares to mop up ₹2092.62 crore.

The Sai Life Sciences IPO sets its price band at 522-549 for each share. A single application for Sai Life Sciences Limited IPO must contain at least 27 shares. Sentiment investors need to invest a minimum of 27 through their retail account. For investors to prevent oversubscription issues, they should submit bids at the cutoff price, which estimates about ₹14,823

As on	QIB	NII bNII sNII	Retail	Total
Shares Offered / Reserved	11,084,225	8,313,168 5,542,113 2,771,056	19,397,392	38,794,785
Day 1 11-12-24 05:00 PM	2.62 x	0.15 0.15 x 0.17 x	0.18 x	0.84 x
Day 2 12-12-24 05:00 PM	3.32 x	0.59 0.58 x 0.62 x	0.42 x	1.25 x
Day 3 13-12-24 05:00 PM	30.93 x	4.92 6.00 x 2.74 x	1.37 x	10.26 x

Total No of Applications

6,46,482

Subscription on the basis of Applications

Retail:0.86x BHNI:0.66x SHNI:2.68x

Sai Life Sciences Valuations

EPS Pre IPO 4.34

EPS Post IPO 2.69

P/E Pre IPO 126.42

P/E Post IPO 203.82

ROE 11.79%

ROCE 15.96%

RoNW 8.13%

PAT Margin 5.65

Price to Book Value 10.18

Sai Life Sciences Company Financials

In Crs.

In Cr.

	31-Mar-24	31-Mar-23	31-Mar-22
Assets	2,275.14	2,186.65	2,164.23
Revenue	1,494.27	1,245.11	897.74
Profit After Tax	82.81	9.99	6.23
Net Worth	974.34	887.29	877.76
Reserves & Surplus	953.99	867.43	859.17
Total Borrowing	710.16	699.23	751.32

About Sai Life Sciences Company

Headquartered in January 1999, Sai Life Sciences Limited is a leading pharmaceutical firm specializing in the research and development and manufacturing of small-molecule new chemical entities (NCEs). It collaborates with global biotech firms and pharmaceutical giants and delivers customized solutions across the drug discovery and development continuum.

In FY 2024, Sai Life Sciences serviced over 280 pharmaceutical innovators, including 18 of the top 25 global pharmaceutical companies by revenue (2023). The company supported more than 230 clients in its key markets, such as the US, UK, Europe, and Japan alone in September 2024.

Sai Life Sciences is different for being an integrated CRDMO, offering end-to-end solutions fully combining discovery, development, and manufacturing. Its CRO services give a solid stage for discovery, and in its CDMO, all scaling is done reliably to take on commercial and developmental work.

Sai Life Sciences - Promoter(s)

Kanumuri Ranga Raju

Krishnam Raju Kanumuri

Kanumuri Mytrey

Sai Quest Syn Private Limited

Sunflower Partners

Lily Partners

Marigold Partners

Tulip Partners

Pre Issue Share Holding : 40.48%

Post Issue Share Holding : 35.10%

Sai Life Sciences IPO - Issue Objectives

Repayment/prepayment in full or part, of all or certain outstanding borrowings availed by the Company

General corporate purposes

Sai Life Sciences IPO - Anchor Investors

Sai Life Sciences mops up Rs 913 crore through anchor book.

Several marquee names in the anchor book including INQ Holdings, Smallcap World Fund, Fidelity, Blackrock, Abu Dhabi Investment Authority, Goldman Sachs, TIMF Holdings, Morgan Stanley, and Eastspring Investments.

HDFC Mutual Fund, Nippon Life India, Axis Mutual Fund, Kotak Mahindra AMC, Aditya Birla Sun Life AMC, DSP MF, Mirae Asset, SBI Life Insurance, UTI Mutual Fund, Whiteoak Capital, Bandhan Mutual Fund, Franklin, HSBC MF, Invesco, Max Life Insurance, Aditya Birla Sun Life Insurance, and Kotak Mahindra Life Insurance among domestic institutional investors also invested in the company.

Sai Life Sciences IPO - Peers Comparison

Company Name	EPS (Basic)	EPS (Diluted)	NAV (per share) (Rs)	P/E (x)	RoNW (%)	P/BV Ratio	Financial statements
Sai Life Sciences Limited	4.57	4.53	53.83	N/A	8.5	N/A	Consolidated
DIVI'S LABORATORIES Limited	60.27	60.27	511.21	103.04	11.79	6.72	Consolidated
Suven Pharmaceuticals Limited	11.8	11.8	94.04	109.37	14.64	7.2	Consolidated
Syngene International Ltd	12.71	12.69	105.91	73.59	11.98	6.69	Consolidated

Notes:

Basic and diluted earnings per equity share are computed by Indian Accounting Standard 33 notified under the Companies (Indian Accounting Standards) Rules of 2015 (as amended).
Net Asset Value per share = Restated equity attributable to owners of our Company / total number of equity shares outstanding during the period.
Return on Net Worth (%) = Restated net profit/(loss) after tax for the years/period attributable to the owners of our Company / by the Net worth as on the last date of the respective period.

Strength

Sai Life Sciences is one of India's largest CRDMOs by revenue.

Diverse product portfolio with 38 products and 7 blockbuster drugs.

Strong R&D infrastructure, offering integrated services and global talent.

Fastest-growing CRDMO with improving profitability and revenue growth metrics.

Weakness

Dependent on biotechnology and pharmaceutical customers, facing industry-specific risks.

Manufacturing delays or interruptions could lead to higher costs and risks.

Heavy reliance on international revenue, facing risks of operational delays.

Contact Details

Sai Life Sciences

Plot No. DS-7, IKP Knowledge Park, Turkapally Village, Shameerpet Mandal, Malkajgiri District, Hyderabad-500078

+9140 6815 6000

investors@sailife.com

https://www.sailife.com/

Registrar Contact Details

Kfin Technologies Limited

04067162222, 04079611000

sailifesciences.ipo@kfintech.com

https://kosmic.kfintech.com/ipostatus/

Sai Life Sciences IPO - FAQs

Ans. Sai Life Sciences Limited IPO is a Mainboard IPO. The issue is priced at ₹522-549 per equity share. The minimum order quantity is 27 Shares. The IPO opens on Dec 11, 2024, and closes on Dec 13, 2024. Kfin Technologies Limited is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.

Ans. The Sai Life Sciences Limited IPO opens on Dec 11, 2024 and closes on Dec 13, 2024.

Ans. You can track the real-time subscription numbers using the links below:

Ans. The size of Sai Life Sciences Limited IPO is Total ₹3,042.62 Cr : #Fresh Issue : 17,304,189 shares(aggregating up to ₹950 Cr) + #OFS : 38,116,934 shares of ₹1(aggregating up to ₹2,092.62 Cr).

Ans. The Sai Life Sciences Limited IPO price band is set between ₹522-549 per equity share.

Ans. To apply for Sai Life Sciences Limited IPO, follow the steps given below:

- Open the IPO Ji App or Website
- Find Sai Life Sciences Limited IPO in the List of IPOs
- Press Apply Button
- Select Your Demat Account
- Select Your Shares Quantity and Submit
- Track Your IPO Status

Ans. The share allotment date of Sai Life Sciences Limited IPO is Dec 16, 2024.

Ans. The Sai Life Sciences Limited IPO will be listed on Dec 18, 2024.

Ans. Follow the steps to check the Sai Life Sciences Limited IPO allotment status online.